Characterization of Residual Limb Volume Changes in Transfemoral Amputees

Characterization of Residual Limb Volume Changes in Transfemoral Amputees: Descriptive Prospective Longitudinal Observational Study.

This study quantifies residual limb volume fluctuations affecting transfemoral amputees due to the prosthesis doffing, physical activity, and testing time.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The first test session aims at measuring residual limb volume at 7 time-points, with 10 minute intervals, after prosthesis doffing. This allows for evaluating the time required for volume stabilization after prosthesis removal, for each amputee. In subsequent sessions, 16 residual limb scans in a day for each amputee are captured to evaluate volume changes due to prosthesis removal and physical activity, in two times per day (one in the morning, one in the afternoon). These measurements are repeated in three different days, a week apart from each other, for a total of 48 scans for each amputee.

Study Type

Observational

Enrollment (Actual)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • BO
      • Bologna, BO, Italy, 40054
        • INAIL Prosthesis Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

transfemoral amputees

Description

Inclusion Criteria:

  • Stabilized (i.e., time since amputation > 18 months) transfemoral amputees
  • Age between 18 and 65 years old
  • Subjects able to safely perform the physical tasks required in the experimental protocol
  • Subjects provided with prostheses

Exclusion Criteria:

  • Denial of informed consent to participate in the study
  • Inability to maintain the required position during the 3D scanning for at least 5 minutes
  • Concomitant general or localized comorbidities / disabilities, which may interfere with the study
  • Pathological conditions affecting the residual limb
  • Allergy / sensitivity with polydimethylsiloxane (PDMS)
  • Pathological cardiopulmonary / cardiovascular conditions
  • Pregnancy or breastfeeding
  • Presence of psychiatric co-morbidities
  • Presence of cognitive deficits which may compromise the understanding of the required tasks
  • Difficulty in understanding the Italian language
  • Insufficient degree of collaboration
  • Consumption of alcohol or diuretics before tests

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Residual limb volume changes
Time Frame: The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks
Residual limb volume changes due to prosthesis doffing, physical activity, and testing time are measured by a proper experimental set-up, including a 3D metrology-grade optical scanner.
The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure distribution at the prosthetic socket - residual limb interface
Time Frame: The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks

Pressure distributions at the residual limb/ socket interface are measured by the F-Socket Pressure Measurement System, during:

  • Walking (five gait cycles, three times);
  • Walking up and down slope (five gait cycles, three times);
  • Walking upstairs and downstairs (six stairs cycles, three times);
  • Sitting down and up (three times).
The protocol consisted of four test sessions in four different days for an overall duration of 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emanuele Gruppioni, INAIL Prosthesis Centre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 11, 2018

Primary Completion (ACTUAL)

August 31, 2020

Study Completion (ACTUAL)

September 30, 2020

Study Registration Dates

First Submitted

January 12, 2021

First Submitted That Met QC Criteria

January 12, 2021

First Posted (ACTUAL)

January 14, 2021

Study Record Updates

Last Update Posted (ACTUAL)

January 14, 2021

Last Update Submitted That Met QC Criteria

January 12, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • P-PPRAI1/2-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation Stump

Clinical Trials on 3D optical scan

3
Subscribe